TXMD Stock: TherapeuticsMD, Inc. Stock Price, Analysis & Insights
Get live txmd stock price $1.55, comprehensive TherapeuticsMD, Inc. stock analysis, charts, news, and expert forecast. Real-time txmd stock data and investment insights.
Loading chart...
Company Overview
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Company Information
- CEO
- Marlan D. Walker
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 1
Contact Information
- Address
- 951 Yamato Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.45) may provide portfolio stability
Business Model & Strategy
TherapeuticsMD, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Marlan D. Walker, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Drug Manufacturers - Specialty & Generic model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
TherapeuticsMD, Inc. competes in the Drug Manufacturers - Specialty & Generic within the broader Healthcare. With 17.9 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, TherapeuticsMD, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating TherapeuticsMD, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for TherapeuticsMD, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for TherapeuticsMD, Inc.
- ⚠Investors should consider how TherapeuticsMD, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
17.94M
P/E Ratio
-31.00
Beta
0.45
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 17.94M market capitalization
- Trading Volume: 15.34K shares traded today
- Price Range: 52-week range of $0.70 - $2.44
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for TherapeuticsMD, Inc.
TherapeuticsMD, Inc. (TXMD) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. With a current market capitalization of 17.94M, the company represents a significant player in its market. The stock is currently trading at $1.55 with a positivedaily change of 1.97%.
The company's 1 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -31.00, beta of 0.45, and 52-week price range from $0.70 to $2.44when evaluating investment opportunities.
Why Invest in TherapeuticsMD, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Marlan D. Walker
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.